World TB Day Coverage: Lesotho, Armenia, Drug Resistance, HIV Coinfection
Main Category: TuberculosisAlso Included In: MRSA / Drug Resistance; HIV / AIDS
Article Date: 26 Mar 2010 - 6:00 PDT
email to a friend
printer friendly
opinions'World TB Day Coverage: Lesotho, Armenia, Drug Resistance, HIV Coinfection'
| Patient / Public: |  | |
| Healthcare Prof: | |
"To mark World [Tuberculosis] Day on Wednesday, Medecins Sans Frontieres [MSF] drew attention to Lesotho, which has the world's third-highest prevalence of HIV ... and the fourth-highest prevalence of tuberculosis," the Associated Press reports. The average life expectancy in the country is just 36 years, according to the AP.
Several factors complicate management of TB and HIV in Lesotho, including violence and poverty, the news service reports. Some people coinfected with HIV and TB "must walk five hours to reach a clinic for their medication," the AP writes, adding that "[m]any men in Lesotho travel to South Africa to work in the mines and some return with HIV and" drug-resistant TB. Between 80 and 90 percent of people living with TB in Lesotho also have HIV, according to Helen Bygrave, a medical coordinator for MSF.
"Most clinics in Lesotho were set up through partnerships between the government and international groups. In seeking ways to make the most of scarce resources, Medecins Sans Frontieres is helping to support and run a program in which nurses are given training to take on roles doctors might have carried out. Community health workers later make sure patients are sticking to their treatment regime," the news service reports (Tay, 3/24). MSF's Web site features a Q&A with Laura Trivino Duran, the MSF tuberculosis programme focal point for the organization's HIV/AIDS program in Lesotho (3/24).
Also on World TB Day, VOA News looked at TB data from the WHO. The agency "says despite continuing efforts against tuberculosis, one-third of the world's population is infected with tuberculosis germs and up to 10 percent of them will become sick or infectious," VOA News writes. Each year, the number of new cases in Southeast Asia, Africa and the eastern Mediterranean continues to rise, according to the WHO. It also "says the disease killed 1.3 million people worldwide in 2008 - most of them in southeast Asia and Africa" (3/24).
In related news, the Sydney Morning Herald examines the emergence of drug-resistant TB and looks at the challenges and prospects of controlling the disease. It focuses on a patient in Armenia and looks at TB control there. "Widespread misuse of the antibiotics created to combat tuberculosis - particularly in the former Soviet Union and China - has led to the emergence of drug-resistant strains that now infect at least half a million people globally each year, less than 3 percent of whom receive proper treatment," according to the newspaper.
The article quotes Mario Raviglione, the head of the WHO's Stop TB Department, who said, ''Rich countries thought TB was a disease of the past ... It's always a problem of 'the others' - a problem of the poorest. But it kills twice as many people as malaria and almost as many as AIDS. If you think this doesn't affect you, you are dead wrong'' (Wroe, 3/25).
Also in light of World TB Day, GlobalPost features a selection of photographs documenting TB in Mumbai, India (Rochkind, 3/24).
This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org.
© Henry J. Kaiser Family Foundation. All rights reserved.
Visit our tuberculosis section for the latest news on this subject.
MLA
31 May. 2012. <http://www.medicalnewstoday.com/releases/183652.php>
APA
http://www.medicalnewstoday.com/releases/183652.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'World TB Day Coverage: Lesotho, Armenia, Drug Resistance, HIV Coinfection'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
